InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022)
InMed Pharmaceuticals' (INM) quarterly Debt Ratio came in at 0.0 in Q1 2022, down 37.41% quarter-over-quarter from 0.0 in Q4 2021.
InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022) Analysis & Trends
InMed Pharmaceuticals' Debt Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |